| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |